{"id":206339,"date":"2025-02-13T03:29:45","date_gmt":"2025-02-13T09:29:45","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/02\/oral-arsenic-trioxide-for-leukemia-has-a-97-cure-rate-hong-kongs-prescription-medicine-enters-international-arena"},"modified":"2025-02-13T03:29:45","modified_gmt":"2025-02-13T09:29:45","slug":"oral-arsenic-trioxide-for-leukemia-has-a-97-cure-rate-hong-kongs-prescription-medicine-enters-international-arena","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/02\/oral-arsenic-trioxide-for-leukemia-has-a-97-cure-rate-hong-kongs-prescription-medicine-enters-international-arena","title":{"rendered":"Oral arsenic trioxide for leukemia has a 97% cure rate: Hong Kong\u2019s prescription medicine enters international arena"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/oral-arsenic-trioxide-for-leukemia-has-a-97-cure-rate-hong-kongs-prescription-medicine-enters-international-arena.jpg\"><\/a><\/p>\n<p>Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of arsenic trioxide (Oral-ATO; ARSENOL) for the treatment of acute promyelocytic leukemia (APL), a blood cancer that once had a high fatality rate.<\/p>\n<p>The invention and use of oral-ATO is of historic importance for medicine in Hong Kong. It is the first-ever prescription medication wholly invented and manufactured in Hong Kong, and also the first to obtain U.S., European and Japanese patents.<\/p>\n<p>After more than two decades of dedicated work, the HKU research team successfully translated this Hong Kong invention into <a href=\"https:\/\/medicalxpress.com\/tags\/clinical+practice\/\" rel=\"tag\" class=\"\">clinical practice<\/a> by incorporating oral-ATO into the treatment plan of APL patients. Extensive <a href=\"https:\/\/ashpublications.org\/blood\/article\/142\/Supplement%201\/157\/499533\/An-Entirely-Oral-Regimen-of-Oral-Arsenic-Trioxide\" target=\"_blank\">clinical studies<\/a> of oral-ATO have demonstrated its high efficacy and safety in curing APL patients, with an overall survival (OS) rate exceeding 97%, along with a significant reduction in side-effects and treatment burden.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of arsenic trioxide (Oral-ATO; ARSENOL) for the treatment of acute promyelocytic leukemia (APL), a blood cancer that once had a high fatality rate. The invention and use of oral-ATO is of historic importance for medicine in [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1522],"tags":[],"class_list":["post-206339","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-innovation"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/206339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=206339"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/206339\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=206339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=206339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=206339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}